Calcium, PTH & Vitamin D Axis

Tempting to order a sestamibi scan since you suspect a parathyroid adenoma and that is the localizing test. But localizing and differentiating are two different questions. Think of sestamibi as a GPS that tells you where the parathyroid is, not what the diagnosis is. FHH and primary hyperPTH both look identical on sestamibi. The 24-hour urine calcium is the diagnostic fork: FHH patients have a CaSR mutation that makes their kidneys hoard calcium (urine Ca/Cr clearance ratio below 0.01), while primary hyperPTH patients leak calcium into the urine. Correct: C -- 24-hour urine calcium.

Both primary hyperPTH and FHH present with hypercalcemia and elevated (or inappropriately normal) PTH. The key difference: in FHH, a CaSR mutation causes the kidney to avidly reabsorb calcium even when Ca is high -- so urine calcium is LOW (calcium-to-creatinine clearance ratio below 0.01). In primary hyperPTH, PTH is driving renal calcium retention too, but not as effectively -- urine calcium is HIGH.

Why the others are wrong: PTHrP would be elevated only in HHM (malignancy), not in either of these conditions. 1,25-OH₂D is elevated in both. Sestamibi scan localizes an adenoma but doesn't differentiate the diagnosis -- operating on FHH is the wrong move and won't fix the hypercalcemia.

Break it down: 24-hour urine calcium separates FHH (low urine Ca, Ca/Cr ratio under 0.01) from primary hyperPTH (high urine Ca); sestamibi only localizes, does not differentiate; operating on FHH is incorrect and harmless surgery.

Tempting to call this hypoparathyroidism since the labs look identical (low Ca, high Phos, low PTH effect). The distinguishing clue is that PTH itself is elevated, not suppressed. Think of Gs-alpha as the power cord that plugs PTH's signal into the cell: PTH arrives at the receptor and tries to deliver its message, but the cord is cut. No cAMP is generated. The parathyroid senses low calcium and keeps secreting more PTH (elevated PTH), but the kidneys and bones cannot hear the signal. It looks like PTH deficiency from the outside but the factory is overproducing. Correct: C -- Gs-alpha inactivating mutation.

This is pseudohypoparathyroidism Type 1a with Albright hereditary osteodystrophy. The parathyroid glands are producing PTH normally (in fact, excessively because they sense low Ca and keep secreting). The problem is at the receptor level: PTH binds its receptor, but the Gs-alpha protein that should transduce the signal into the cell is defective. No cAMP is generated. The kidney and bone cannot respond. Result: same lab pattern as hypoparathyroidism but PTH is elevated, not suppressed.

AHO phenotype clues: short stature, short 4th/5th metacarpals (ringer and pinky), round face, intellectual disability. The shortened metacarpals are pathognomonic -- ask the patient to make a fist and the knuckle is absent where the others would be.

Break it down: pseudohypoparathyroidism = PTH elevated (parathyroids working) but end-organ resistance (Gs-alpha defective); distinguishes from true hypoparathyroidism (PTH low); AHO phenotype = short 4th/5th metacarpals + round face + intellectual disability.

Tempting to blame the lung disease itself or hyperparathyroidism since sarcoidosis and hypercalcemia seem unrelated. The link is an enzyme running unsupervised. Think of 1-alpha-hydroxylase in the kidney as a regulated factory machine: PTH turns it on and off. When granuloma macrophages get the blueprint and install their own copy, the machine runs 24/7 with no off switch. Excess calcitriol pours out, gut calcium absorption skyrockets, and PTH drops because the body senses the flood and tries to brake. The brake works, the factory does not care. Correct: C -- macrophage 1-alpha-hydroxylase making excess calcitriol; treat with steroids.

In sarcoidosis and other granulomatous diseases (TB, histoplasmosis, berylliosis), activated macrophages inside granulomas express 1-alpha-hydroxylase. This enzyme normally only operates in the kidney under PTH control. In granuloma macrophages, it runs unchecked -- making large amounts of 1,25-(OH)₂D even without PTH. The excess calcitriol drives Ca absorption in the gut and bone resorption, causing hypercalcemia. PTH is suppressed because the body correctly tries to turn off the axis.

Key: glucocorticoids work here because they block macrophage 1-alpha-hydroxylase activity. Bisphosphonates don't address the mechanism. Surgery and PTH are not the problem. Restricting VitD intake helps marginally but the main source is endogenous macrophage production.

Break it down: granulomatous disease hypercalcemia = macrophage 1-alpha-hydroxylase running unchecked; excess calcitriol drives gut Ca absorption; PTH is suppressed (not the cause); treat with glucocorticoids (block macrophage hydroxylase).

Tempting to give calcium directly since the problem is low calcium. But calcium infusion in the setting of low magnesium is like filling a bucket with a hole: the kidney excretes the calcium immediately because PTH cannot tell it to retain calcium. Think of magnesium as the lubricant in two specific machines in the PTH assembly line: the first machine (chief cell exocytosis) cannot package and release PTH without it, and the second machine (Gs-alpha signal transduction) cannot transmit the PTH signal without it. Both machines fail simultaneously when magnesium is depleted. Correct: C -- replace magnesium IV.

Magnesium is required at two points in the PTH axis: (1) for PTH secretion by chief cells (exocytosis is Mg-dependent), and (2) for G-protein signal transduction at the PTH receptor (Gs-alpha needs Mg to function). With Mg at 0.8, both steps are blocked. Even if a little PTH is secreted, the kidneys and bone cannot respond to it. Infusing calcium provides temporary relief but the kidney immediately excretes it because PTH cannot tell the kidney to retain calcium.

Clinical rule: Any hypocalcemia refractory to supplementation = check magnesium. If low, Mg must be replaced first -- the Ca simply will not stick until the PTH axis is functional again. IV magnesium sulfate is the treatment. Classic context: alcoholic, PPI user, cisplatin or amphotericin therapy.

Break it down: hypomagnesemia blocks PTH secretion (exocytosis) AND PTH receptor transduction (Gs-alpha); calcium supplementation fails because kidneys cannot retain it without functional PTH; fix Mg first, then Ca; refractory hypocalcemia = check magnesium always.